Hair Diseases
7
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
a Retrospective Study on the Systemic Treatment of LPP and FFA
Local Anesthesia and Electronic Injector
Systemic Treatments for Alopecia Areata Registry
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
Suppression of Upper Lip Hair Growth Using Novel Hemp Extract